To exploit the P licence for Omacor – the only omega-3 PUFA licensed for secondary prevention post-MI - by developing a direct-to-consumer campaign piloted in the Greater Manchester and Belfast regions, which are areas of high use and hospital endorsement of Omacor.
The
Solution:
A simple, factual campaign utilising local press, Adshel posters, information packs for HCPs, waiting room posters and leaflets, radio and TV advertising (on GMTV) to encourage post-MI patients and carers to ask their healthcare professional about Omacor.
The
Brief:
To overcome GP resistance to prescribing Omacor, which
is not recommended as part of the standard post-MI
regimen.
The
Solution:
Life developed "The Beach" a new advertising
campaign to increase the emotional pressure on prescribers,
combining a "real life" depiction of an MI
survivor with the new NICE recommendation, making Omacor
a "heart and mind" decision.
The
Brief:
To create a new campaign for Xomolix, an effective product for the prevention of postoperative nausea and vomiting in at-risk patients.
The
Solution:
Life created a memorable and impactful core concept to dramatise patients' fears about nausea and vomiting after an operation, creating an emotional reason for anaesthetists to use Xomolix before surgery.
